Clinical Trials Directory

Trials / Terminated

TerminatedNCT00288262

Melatonin Effects on Luteinizing Hormone

Status
Terminated
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
20 (planned)
Sponsor
Scripps Health · Academic / Other
Sex
Female
Age
50 Years – 70 Years
Healthy volunteers
Not accepted

Summary

In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human reproductive endocrinology are uncertain. It is thought that the same hypothalamic pulse generator may both trigger the pulsatile release of GnRH and LH and also cause hot flashes. Thus, if melatonin suppressed this pulse generator in postmenopausal women, it might moderate hot flashes. This clinical trial tested the hypothesis that melatonin could suppress LH and relieve hot flashes.

Detailed description

Twenty postmenopausal women troubled by hot flashes underwent one week of baseline observation followed by 4 weeks of a randomized controlled trial of melatonin or matched placebo. The three randomized treatments were melatonin 0.5 mg 2.5-3 hours before bedtime, melatonin 0.5 mg upon morning awakening, or placebo capsules. Twelve of the women were admitted to the GCRC at baseline and at the end of randomized treatment for 24-hour sampling of blood for LH. Morning urine samples were collected twice weekly to measure LH excretion. Subjective responses measured throughout baseline and treatment included sleep and hot flash logs, the CESD and QIDS depression self-ratings, and the SAFTEE physical symptom inventory.

Conditions

Interventions

TypeNameDescription
DRUGmelatonin 0.5 mg

Timeline

Start date
2004-06-01
Completion
2005-02-01
First posted
2006-02-07
Last updated
2006-02-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00288262. Inclusion in this directory is not an endorsement.